Goldman Sachs Starts Surface Oncology (SURF) at Neutral
Tweet
Share
E-mailGet Alerts SURF Hot Sheet
Price: $1.07 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Join SI Premium – FREE
Goldman Sachs initiates coverage on Surface Oncology (NASDAQ: SURF) with a Neutral rating and a price target of $17.00.
For an analyst ratings summary and ratings history on Surface Oncology click here. For more ratings news on Surface Oncology click here.
Shares of Surface Oncology closed at $14.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'
- Nomura/Instinet Resumes Kobe Bussan Co Ltd (3038:JP) at Neutral
- Craig-Hallum Reinstates FuelCell Energy (FCEL) at Buy, 'The Emerging Data Center Opportunity Provides The Path'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
